Aclaris Therapeutics, Inc. - Special Call

Group 1 - Aclaris held its 2025 R&D Day in New York, indicating a focus on research and development initiatives [1] - The event was attended by both in-person participants and those joining via webcast, highlighting the company's commitment to stakeholder engagement [1] - The presentation included forward-looking statements, which are subject to risks and uncertainties that may affect actual results [2]